معرفی
Per Hydbring is a Senior Research Specialist and Lecturer at the Department of Oncology-Pathology, Karolinska Institutet, where he leads his research team focused on coding and non-coding RNAs in cancer. His work intersects with Simon Ekman's Precision Cancer Medicine in Lung Cancer group, emphasizing targeted therapy resistance and RNA-based drug delivery.
- Academic Affiliation: Department of Oncology-Pathology, Karolinska Institutet
- Research Focus: MicroRNA mechanisms in therapy-resistant lung and breast cancers, cell cycle regulation via CDKs/cyclins, and systemic RNA delivery using lipid nanoparticles
His research employs systematic genomic screens to identify RNA regulators of tumor refractoriness to tyrosine kinase inhibitors (TKIs) like osimertinib, with applications in patient outcome prediction and drug development. Collaborations include teams led by Dr. Simon Ekman and Dr. C. Norberg, supported by the Swedish Research Council and Stockholm Cancer Society. Dr. Hydbring obtained his Docent degree at Karolinska Institutet in 2023.
